Calcium Carboxymethyl Cellulose Market

The carboxymethylcellulose calcium market is projected to grow from USD 0.06 billion in 2026 to USD 0.09 billion in 2036, at a CAGR of 4.8% during the forecast period.

Carboxymethylcellulose calcium is a functional cellulose derivative produced by chemically modifying cellulose and converting it into its calcium salt. It is primarily used as a pharmaceutical excipient because of its high water-absorption and swelling capacity. When incorporated into tablets, it rapidly absorbs liquid and swells, facilitating tablet breakup and supporting the release of the active pharmaceutical ingredient. Its functionality can vary according to particle-size distribution, degree of substitution, moisture content, bulk density, swelling capacity, and hydration behavior. These characteristics make carboxymethylcellulose calcium suitable for applications requiring efficient disintegration and consistent formulation performance. It is mainly used in oral solid dosage formulations, including tablets and capsules, and can also provide binding, stabilization, and moisture-management functionality in selected formulations. Manufacturers can differentiate grades by controlling physical and functional properties to meet specific formulation and processing requirements, particularly for direct compression, wet granulation, and orally disintegrating formulations.

To know about the assumptions considered for the study download the pdf brochure

The carboxymethylcellulose calcium market is primarily supported by the pharmaceutical industry's continued demand for functional excipients used in oral solid dosage formulations. Increasing production of generic medicines, over-the-counter products, and high-volume tablet formulations is supporting consumption, while pharmaceutical manufacturers are placing greater emphasis on excipient consistency, predictable disintegration, powder flow, swelling behavior, and compatibility with active pharmaceutical ingredients. This is creating opportunities for suppliers to develop performance-specific grades with optimized particle size, flowability, compactibility, moisture content, and swelling characteristics. Asia Pacific represents an important growth region because of its expanding pharmaceutical manufacturing base, particularly in India and China, while North America and Europe remain significant markets because of their established pharmaceutical industries and stringent quality requirements. Competitive positioning depends on pharmaceutical-grade quality, regulatory compliance, batch-to-batch consistency, technical support, and supply reliability. In addition to pharmaceuticals, the broader scope includes medical devices & wound care, nutraceuticals & dietary supplements, cosmetics & personal care, and other end-use industries, although pharmaceutical applications remain the principal demand center for carboxymethylcellulose calcium.

The global carboxymethylcellulose calcium market is characterized by the presence of established pharmaceutical excipient manufacturers and specialty cellulose derivative producers, with key companies having strong manufacturing and distribution capabilities across Europe, North America, and Asia Pacific. Key market participants include Anmol Chemicals Private Limited (India), Spectrum chemicals (US), BOLAK Co., Ltd. (South Korea), Maple Biotech Pvt Ltd (India), Patel Chem Specialties Limited (India), Amit Hydrocolloids (India), Hiranya Cellulose Products (India), Jiangxi Alpha Hi-tech Pharmaceutical Co., Ltd. (China), Prachin Pharmachem (India), Maruti Chemicals (India), Amishi Drugs & Chemicals (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), and Gotoku Chemical Co., Ltd. (Japan). These companies are focused on supplying pharmaceutical-grade carboxymethylcellulose calcium with consistent physicochemical properties, expanding excipient portfolios, strengthening regulatory and technical support, and developing grades optimized for different oral solid dosage formulations and manufacturing processes.

Gotoku Chemical Co., Ltd. (Japan)

Gotoku Chemical Co., Ltd. is a Japanese specialty pharmaceutical excipient company focused on the research, development, and commercialization of cellulose-based disintegrants. The company pioneered the development of Carmellose Calcium in Japan and commercialized it under the E.C.G.-505 brand in 1961. It has played a significant role in the evolution of pharmaceutical disintegrants, with E.C.G.-505 being listed in the Japanese Pharmacopoeia (JP), USP-NF, European Pharmacopoeia (Ph. Eur.), and Chinese Pharmacopoeia (ChP). The company also maintains US and China Drug Master Files (DMFs) for the product and supplies its pharmaceutical excipients to more than 200 pharmaceutical companies in Japan and customers in over 70 countries.

Anhui Sunhere Pharmaceutical Excipients Co., Ltd.  (China)

Anhui Sunhere Pharmaceutical Excipients is one of China's largest manufacturers of pharmaceutical excipients, with a business centered on the research, development, and production of functional excipients for the pharmaceutical and food industries. Established in 2001, the company operates a manufacturing base in Huainan, Anhui Province, and serves customers across China as well as Europe, the Americas, and Southeast Asia. Sunhere also contributes to the compilation of the Chinese Pharmacopeia, reflecting its active role in the country's pharmaceutical excipient industry. The company manufactures a broad portfolio of cellulose derivatives, starch derivatives, tablet coating materials, inorganic salts, and other excipients, supported by 22 patents and certifications including US-DMF, EXCiPACT, CEP, Halal, Kosher, FSSC 22000, and RSPO.

Among its cellulose derivatives, Sunhere manufactures Carboxymethylcellulose Calcium (Carmellose Calcium) for pharmaceutical applications, complementing its portfolio of tablet disintegrants and formulation excipients. The company combines large-scale GMP-compliant manufacturing with in-house R&D, analytical testing, and regulatory support to develop excipients that comply with major international pharmacopeial standards. Its focus on innovation, regulatory compliance, and customized excipient solutions has enabled the company to establish a strong presence in both domestic and international pharmaceutical markets.

METAL ORGANIC FRAMEWORKS MARKET: MARKET RANKING

The carboxymethylcellulose calcium market is competitive, with the top five players accounting for 31–36% of the total market share. The industry comprises a mix of established pharmaceutical excipient manufacturers and regional players competing through product quality, regulatory compliance, product innovation, capacity expansions, and investments in pharmaceutical-grade carboxymethylcellulose calcium. The major players active in the carboxymethylcellulose calcium market are based in Asia Pacific, Europe, and North America. Anmol Chemicals Private Limited (India), Spectrum chemicals (US), BOLAK Co., Ltd. (South Korea), Maple Biotech Pvt Ltd (India), Patel Chem Specialties Limited (India), Amit Hydrocolloids (India), Hiranya Cellulose Products (India), Jiangxi Alpha Hi-tech Pharmaceutical Co., Ltd. (China), Prachin Pharmachem (India), Maruti Chemicals (India), Amishi Drugs & Chemicals (India), Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China), and Gotoku Chemical Co., Ltd. (Japan) are among a few leading players operating in the carboxymethylcellulose calcium market.

Many leading players are adopting a range of growth strategies to strengthen their global footprint and competitive position in the carboxymethylcellulose calcium market. These strategies include new product launches, strategic partnerships, contract agreements, capacity expansions, and continuous product development, all focused on expanding their market presence and meeting evolving pharmaceutical formulation and excipient requirements.

Related Reports:

Carboxymethylcellulose Calcium Market by Form (Fine Powder, Standard Powder), Grade (Pharmaceutical Grade, Food Grade), End-use Industry, and Region - Global forecast to 2036

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]